Name | Number of supported studies | Average coverage | |
---|---|---|---|
hepatocyte | 4 studies | 31% ± 15% | |
glutamatergic neuron | 3 studies | 29% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 26% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3601.31 | 1438 / 1445 | 100% | 24.83 | 183 / 183 |
lung | 99% | 2770.69 | 575 / 578 | 99% | 19.65 | 1148 / 1155 |
intestine | 100% | 4970.58 | 966 / 966 | 98% | 15.24 | 519 / 527 |
breast | 100% | 2599.39 | 457 / 459 | 99% | 19.18 | 1104 / 1118 |
pancreas | 99% | 3267.08 | 324 / 328 | 99% | 18.60 | 177 / 178 |
prostate | 100% | 3068.59 | 245 / 245 | 98% | 16.02 | 493 / 502 |
brain | 98% | 2334.61 | 2591 / 2642 | 100% | 30.46 | 705 / 705 |
bladder | 100% | 5064.33 | 21 / 21 | 98% | 14.75 | 494 / 504 |
liver | 98% | 4907.94 | 222 / 226 | 100% | 40.84 | 404 / 406 |
uterus | 100% | 4975.51 | 170 / 170 | 98% | 19.10 | 448 / 459 |
stomach | 100% | 3879.52 | 359 / 359 | 97% | 17.31 | 278 / 286 |
kidney | 100% | 1979.75 | 89 / 89 | 95% | 14.09 | 860 / 901 |
ovary | 100% | 2874.58 | 180 / 180 | 95% | 11.55 | 408 / 430 |
skin | 100% | 3593.99 | 1807 / 1809 | 94% | 21.37 | 444 / 472 |
adrenal gland | 98% | 2859.65 | 253 / 258 | 93% | 18.11 | 214 / 230 |
thymus | 99% | 1843.66 | 648 / 653 | 91% | 9.64 | 552 / 605 |
blood vessel | 100% | 5535.76 | 1335 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 12543.11 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2323.22 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.70 | 1 / 1 |
adipose | 98% | 2734.02 | 1179 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 13.82 | 44 / 45 |
heart | 95% | 3142.09 | 816 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 79% | 9.62 | 63 / 80 |
lymph node | 0% | 0 | 0 / 0 | 72% | 5.45 | 21 / 29 |
peripheral blood | 30% | 492.25 | 279 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0120162 | Biological process | positive regulation of cold-induced thermogenesis |
GO_0031588 | Cellular component | nucleotide-activated protein kinase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0019901 | Molecular function | protein kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0004679 | Molecular function | AMP-activated protein kinase activity |
Gene name | PRKAB2 |
Protein name | AMP-activated protein kinase beta 2 non-catalytic subunit isoform A AMP-activated protein kinase beta 2 non-catalytic subunit isoform B 5'-AMP-activated protein kinase subunit beta-2 (AMPK subunit beta-2) AMP-activated protein kinase beta 2 non-catalytic subunit isoform C |
Synonyms | |
Description | FUNCTION: Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3). FUNCTION: Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3). . FUNCTION: Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3). . |
Accessions | X5D2S2 ENST00000254101.4 [O43741-1] X5D9J1 O43741 X5D2Z8 |